Post-Ch. 11 Teligent 'Caremark' Suit Moves Forward In Del.

By Jeff Montgomery · September 2, 2025, 3:58 PM EDT

In a rare decision, Delaware's chancellor on Tuesday kept alive "Caremark" duty of oversight claims against most former officers and directors of a generic-drug maker previously known as Teligent....

To view the full article, register now.